Objectives NADH cytochrome b 5 reductase (b5R) and cytochrome b 5 (b5) catalyze the reduction of sulfamethoxazole hydroxylamine (SMX-HA), which can contribute to sulfonamide hypersensitivity, to the parent drug sulfamethoxazole. Variability in hydroxylamine reduction could thus play a role in adverse drug reactions. The aim of this study was to characterize variability in SMX-HA reduction in 111 human livers, and investigate its association with single nucleotide polymorphisms (SNPs) in b5 and b5R cDNA.
Introduction
The antimicrobial drug sulfamethoxazole (SMX) is associated with delayed hypersensitivity reactions in 1-3% of the general population [1] , with a higher incidence in immunocompromised patients [2, 3] . SMX is oxidized to its hydroxylamine (SMX-HA) by CYP2C9 [4] or myeloperoxidase [5] ; the hydroxylamine is spontaneously oxidized to an unstable nitroso metabolite (SMX-NO) [6] , which is thought to be the proximate immunogen in SMX hypersensitivity reactions [7, 8] . SMX-HA and other hydroxylamines are reduced by cytochrome b 5 reductase (b5R) and cytochrome b 5 (b5) in the endoplasmic reticulum [9, 10] . This pathway also detoxifies dapsone hydroxylamine [9] , as well as hydroxylamines of the carcinogens 4-aminobiphenyl and 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine [10] . Thus, the microsomal b5/b5R pathway may be clinically and toxicologically important, as it counters the bioactivation of hydroxylamine-forming xenobiotics. Consequently, variability in the activity of this reduction pathway is likely to have direct consequences on the disposition and toxicity of clinically important xenobiotics.
The cytochrome b 5 (CYB5A) and the NADH cytochrome b 5 reductase (CYB5R3) genes are well characterized. Each gene generates two major splice variants, a soluble cytosolic form found in erythrocytes, and a membranebound protein predominantly located in the endoplasmic reticulum of hepatocytes and other tissues [11] [12] [13] . However, individual variability in the expression of CYB5R3 and CYB5A has not been well characterized.
Two nonsynonymous cSNPs in CYB5A, R52K and Y130X, have been reported in the NCBI SNP database, and eight nonsynonymous cSNPs have been identified to date for CYB5R3; however, the functional significance, if any, of these and other cSNPs has not been determined.
Although earlier studies have shown significant individual differences in soluble b5/b5R activity (as measured by erythrocyte methemoglobin reduction) [14, 15] , no genotype-phenotype correlations have been performed for either isoform. Our previous data on microsomes from 27 human livers indicated nearly 10-fold variability in SMX-HA reduction, with a similar range of b5 protein expression but lesser variability in b5R expression [10] . We recently identified a cSNP in CYB5A (T60A) in a screen of leukocyte cDNA from 63 individuals; this cSNP was associated with a 70% decrease in b5 protein expression in vitro [16] . However, the prevalence of this cSNP is not yet clear.
The objectives of this study, therefore, were to characterize the range of hydroxylamine reduction activities in a relatively large sample of normal human livers, and to perform genotype-phenotype correlations between cSNPs in the genes encoding the microsomal forms of b5 and b5R and hydroxylamine reduction. To meet these objectives, we phenotyped SMX-HA reduction activities in 111 human livers, along with immunoblotting for b5 and b5R protein expression, and resequenced CYB5A and CYB5R3 cDNAs in all livers to screen for coding sequence or splice junction polymorphisms.
Methods Liver samples
Human liver tissue was obtained from the Midwest Division of the Cooperative Human Tissue Network, and in collaboration with Dr Sharon Weber, from the Division of General Surgery, University of Wisconsin-Madison. Tissue samples were taken from grossly normal margins of excised benign or metastatic liver lesions from adult patients of any race or either sex. Patients with prior intra-abdominal radiation therapy were ineligible. Liver samples were snap frozen in liquid nitrogen and then stored at -801C until use. All participants provided informed consent, and all procedures were approved by the Institutional Review Board of the University of Wisconsin-Madison. A sample size of greater than 100 livers was chosen to provide more than 95% chance of finding a single nucleotide polymorphism (SNP) with an allele frequency of 1% [17] .
Subcellular fractionation
Approximately 1 g of liver tissue was homogenized in Dulbecco's phosphate-buffered saline (PBS), pH 7.4, and centrifuged at 9000g. The resulting nuclear pellet was stored at -801C for genomic DNA extraction, if needed. The supernatant was further centrifuged at 100 000g for 60 min to obtain microsomal and cytosolic fractions, which were stored at -801C. Protein content determination was carried out using the Bradford assay (Bio-Rad, Hercules, California, USA).
Sulfamethoxazole hydroxylamine reduction assay and kinetics SMX-HA (Wilmington PharmaTech, Newark, Delaware, USA) was dissolved in 50% dimethyl sulfoxide with 3 mmol/l ascorbic acid, whereas SMX (Sigma, St. Louis, Missouri, USA) was dissolved in an aqueous solution of 50% dimethyl sulfoxide. Reduction activities were determined by incubating 125 mg of microsomal protein with 200 mmol/l of SMX-HA and 1 mmol/l of NADH in PBS, pH 7.4, at 371C for 15 min. Reduced glutathione and ascorbic acid (both at a final concentration of 1 mmol/l) were included to prevent hydroxylamine autooxidation [18] . Negative controls and SMX standards included human serum albumin (125 mg; Sigma) in place of microsomal protein. After reaction termination by the addition of ice-cold methanol, the proteins were pelleted out by centrifugation, and the resulting filtered supernatant was analyzed by gradient high-performance liquid chromatography with UV detection at 256 nm. The highperformance liquid chromatography conditions were as follows: solvent A consisted of an aqueous solution of 1% acetic acid and 0.05% triethylamine; solvent B was 100% acetonitrile, at a flow rate of 2 ml/min. The percentage of solvent B in the mobile phase mixture was initially 10% for 5 min, increased to 30% over 7 min, kept at 30% for 11 min, and finally returned back to 10% over 13 min. SMX product formation was quantified by means of peak heights from an SMX standard curve.
SMX-HA reduction kinetics were determined for a subset of human livers (n = 18) that had no cSNPs in CYB5A and CYB5R3 and represented a range of SMX-HA reduction activities (high: > 90th percentile of activities for the population; intermediate: 45-55th percentile; and low: < 10th percentile). Kinetics were also determined for all livers that were found to have nonsynonymous CYB5A or CYB5R3 cSNPs. Kinetic experiments were performed under initial-rate conditions at a concentration range of 50-3000 mmol/l SMX-HA. Data were fit to the Michaelis-Menten equation and apparent kinetic parameters were estimated using GraphPad Prism 5 (GraphPad Software, San Diego, California, USA). For those livers exhibiting nonlinear kinetics, fitting into several two-site and two-enzyme models resulted in nonsensical estimates of kinetic parameters; for these livers, data from Hanes plots were used to derive initial estimates of K m and V max for high and low-substrate affinity components. An iterative technique was used to account for the contributions of each component at the substrate range used. The process was repeated until convergence was obtained [19] .
b5 and b5R immunoblot analysis
To determine the relationship between b5 and b5R expression and SMX-HA reduction in human liver, rabbit polyclonal antisera to b5 or b5R [9] were used to probe immunoblots prepared from individual human liver microsomal proteins (30 mg). The same blot was probed for both b5 and b5R, along b-actin to control for lane loading. Each blot was probed in the following order: b-actin control, b5, and b5R. As the b-actin and b5R
proteins are similar in size, the polyvinylidene fluoride (PVDF) membranes were stripped for 30 min at 371C in Restore Plus Western Blot Stripping Buffer (Pierce Biotechnology, Rockford, Illinois, USA) before b5R immunoblotting. Immunoblotting was performed twice per sample, from separate gels (15% Tris-HCl; Bio-Rad, Hercules, California, USA). After semi-dry transfer, PVDF membranes (0.45 mm; Pierce Biotechnology) were blocked with 5% non-fat dry milk in Dulbecco's PBS/0.1% Tween-20 for 1 h and washed with Dulbecco's PBS/0.1% Tween-20. For loading controls, mouse monoclonal to b-actin, tagged with horseradish peroxidase (Abcam, Cambridge, Massachusetts, USA), was diluted 1 : 5000 and incubated with PVDF membranes for 2 h at 41C. Rabbit polyclonal anti-human b5 and b5R antisera, diluted 1 : 10 000 [9] , were each incubated overnight with the PVDF membrane. The secondary antibody, peroxidase-conjugated donkey anti-rabbit IgG (Jackson Immunoresearch Laboratories, West Grove, Pennsylvania, USA), was diluted 1 : 10 000 and immunoblotted for 2 h at 41C. Bound antibody for all experiments was detected by chemiluminescence (Super Signal West Pico, Pierce) using a UVP imaging system (UVP, Upland, California, USA) and quantified by ImageJ software (http://rb.info. nih.gov/ij). Densitometries for bands corresponding to immunoreactive b5 and b5R were each normalized to immunoreactive b-actin.
Resequencing of cDNA for CYB5A and CYB5R3
Total RNA was isolated from 80 mg of individual human liver tissue using the RNAqueous-4PCR kit (Ambion, Austin, Texas, USA). Reverse transcription PCR was performed using the RETROscript KIT (Ambion). Primers were designed to amplify the entire coding sequences of CYB5A and CYB5R3 (Table 1 ). For amplification of microsomal CYB5A cDNA, the thermocycler parameters were as follows: initial denaturation at 941C for 2 min, 35 cycles at 941C for 15 s, 511C for 25 s, and 721C for 30 s, followed by a final extension of 721C for 7 min. For amplification of microsomal CYB5R3 cDNA, a touchdown PCR method was developed: initial denaturation at 951C for 2 min, then 38 cycles at 951C for 30 s, 71-671C for 30 s (2 cycles per degree), followed by 28 cycles at the touchdown temperature of 661C and 721C for 1 min 15 s, followed by a final extension at 721C for 7 min.
Four microliter aliquots of each PCR reaction were used to cycle sequence the CYB5A and CYB5R3 cDNA amplicons in both directions using BigDye Terminator v3.1 reagents (Applied Biosystems, Foster City, California, USA). The amplified fragments were submitted to the UW-Madison Biotechnology Core for magnetic bead cleanup and subsequent analysis on an ABI 3700 DNA sequencer. Sequences were aligned using the Staden Package (http://staden.sourceforge.net) and any sequence variants from the published wild-type (WT) sequence (NM_148923 for CYB5A, NM_000398 for CYB5R3) were confirmed by repeat sequencing with specific primers ( Table 1 ). The SNPs were also confirmed by direct inspection of sequencing chromatograms, which are available on request from the authors. The first A in the ATG translation initiation codon and the initial methionine residue were designated as + 1 for the cDNA and protein, respectively, in accordance with the accepted nomenclature (http://www.hgvs.org/mutnomen/recs. html [20] ). The numbering system used for older b5 and b5R studies mentioned in this study designates the first amino acid of the mature protein as + 1. To allow comparisons, amino acid changes referred to in previous studies will be identified using the currently recommended nomenclature.
Genomic DNA extraction
Confirmation of one SNP (CYB5A S5A; see below) necessitated designing an appropriate forward primer to anneal to the 5 0 untranslated region of exon 1 of CYB5A (Table 1) . This required genomic DNA as a template, which was extracted from 12 mg of liver nuclear fraction using the DNeasy Tissue Kit (Qiagen, Valencia, California, USA).
Data analyses and prediction of single nucleotide polymorphism impact SPSS statistical software (SPSS Inc., Chicago, Illinois, USA) was used to analyze population and outlier activities, kinetics, and expression data. A P value of less than 0.05 was considered significant. Pearson's correlation or Spearman's rank correlation for non-normally distributed data were used to investigate relationships among activities, age, and protein expression. Group means were compared through a one-way analysis of variance (ANOVA) with Tukey's honestly significantly different test; for non-normally distributed data, Kruskal-Wallis was used. Analysis of allele frequencies between different races was carried out using the Fisher's exact test. Associations among sex and race, and either SMX-HA reduction activities or b5/b5R protein expression, were investigated by using a general linear model univariate procedure to perform a two-way ANOVA with post-hoc Tukey honestly significantly different test. Possible interactions between sex and race on activity and protein expression were investigated by estimating the marginal means, which are the group means after controlling for a covariate. Multiple regression analysis was used to verify the association between reduction activities and b5 or b5R expression when controlling for either b5 or b5R expression, with a given b coefficient indicating how much the predicted value of activity changes each time the expression of one protein increases by one unit, while keeping the expression of the other protein constant.
Haplotype analysis, including testing alleles for HardyWeinberg equilibrium, testing the significance of D 0 between two loci, and haplotype association tests with SMX-HA reduction activities were carried out by the Haploview 4.1 software package [21] .
Several studies have shown that the impact of amino acid allelic variants on protein structure and function can be predicted by analysis of multiple sequence alignments and three-dimensional protein structures [22] [23] [24] . The following computational amino acid substitution predictive methods were therefore used: SIFT (http://blocks. fhcrc.org/sift/SIFT.html) [24] , PolyPhen (http://genetics.bwh. harvard.edu/pph/) [24] , and PMut (http://mmb2.pcb.ub. es:8080/PMut/) [22] . SIFT is based on the premise that important amino acids in a specific protein will be conserved across various species, whereas PolyPhen predicts the impact of nonsynonymous SNPs on threedimensional protein structure and function. PMut combines evolutionary information with structural data for the prediction of pathological mutations. The neural network servers, Netphos [25] (available at http:// www.cbs.dtu.dk/services/NetPhos/) and NetphosK [26] (available at http://www.cbs.dtu.dk/services/NetPhosK/), were used to predict phosphorylation sites for serine and threonine residues affected by SNPs.
Results
Hepatic SMX-HA reduction activities ranged from 0.06 to 1.11 nmol/min/mg protein ( Fig. 1) , with one sample showing no detectable activity. Mean (± SD) SMX-HA reduction activity was 0.52 ± 0.24 nmol/min/mg microsomal protein (95% confidence interval=0.47-0.57). SMX-HA reduction activities were not correlated with age (r = -0.145, P = 0.13). However, SMX-HA reduction activities in Caucasian-Americans (CA) (0.55 ± 0.22 nmol/min/mg; n = 93) were significantly higher than in African-Americans (AA) (0.32 ± 0.29 nmol/min/mg; n = 15) (P = 0.003; Table 2 ). In particular, reduction activities in CA females (0.59 ± 0.23 nmol/min/mg; n = 52) were significantly higher than those in AA females (0.28 ± 0.25 nmol/min/mg; n = 9; P = 0.001). Estimated marginal means did not reveal any interaction between sex and race-related differences in activity. Mean ( ± SD) SMX-HA reduction activities, and median (interquartile range) b5 and b5R protein expression in immunoreactive units, relative to b-actin.
Groups were compared using a two-way analysis of variance with post-hoc Tukey honestly significantly different test and Tamhane's T2 test to explore any possible interactions of sex and race to observed differences in phenotype. AA, African-Americans; CA, Caucasian-Americans; SMX-HA, sulfamethoxazole hydroxylamine. *P = 0.003, relative to all CA individuals. Data from four livers were excluded from this analysis, including three livers from females of unknown race and one CA liver from an individual of unrecorded sex. **P = 0.001 relative to CA females. ***Trend P = 0.078 for lower b5 expression in AA females relative to CA females.
Immunoreactive b5 and b5R protein expressions exhibited five-fold and nine-fold ranges among individuals, respectively, and were not normally distributed. Immunoreactive b5 and b5R proteins were both undetectable in two livers; these livers displayed very low SMX-HA reduction activities (0.06 and 0.07 nmol/min/mg). The single liver sample with no detectable SMX-HA reduction activity exhibited a 30% decrease in both b5 and b5R protein expressions compared with median protein expression in the population.
The expression of both b5 and b5R was positively correlated with SMX-HA reduction activities (r = 0.42, P < 0.0001 for b5; r = 0.23, P = 0.01, for b5R). Multiple regression analysis showed that b5 and b5R expressions could account for the 12.5% of variability observed in SMX-HA reduction activity in this population, with b5 having more apparent impact than b5R [b coefficient (± SE)=0.07 (± 0.03) for b5 and 0.004 (± 0.02) for b5R]. Interestingly, the expression of these two proteins was also significantly correlated with one another (r = 0.74, P < 0.0001) (Fig. 2) .
Neither b5 nor b5R expression was correlated with age, and there were no significant differences in b5 or b5R expression between AA and CA (P = 0.204). The estimated marginal means revealed an interaction between sex and ethnicity, suggesting that CA females had higher b5 expression than CA males, although this apparent interaction did not reach significance (P = 0.063). In AA males and females, expression of b5 and b5R accounted for 95.5 and 82.8%, respectively, of the variability in activities (males: ANOVA F=15.7, P = 0.03; females: F=14.4, P = 0.005).
The occurrence of CYB5A and CYB5R3 SNPs in the coding region of the microsomal isoforms was investigated for 111 human livers. Agarose gel electrophoresis of CYB5A and CYB5R3 cDNA did not reveal any amplicon of unexpected size in any patient. All alleles found at each locus were in random association with one other, as expected under Hardy-Weinberg equilibrium conditions. One novel nonsynonymous cSNP was found in CYB5A (S5A), whereas two novel nonsynonymous cSNPs were discovered for CYB5R3 (R59H and R297H) ( Table 3 ). All were in the heterozygous state. The CYB5A T60A SNP, which was originally identified in an AA male [17] , was not found in this population, although only 15 AAs were available.
The CYB5A S5A SNP was found in two AA individuals, one male and one female. Activities for these two livers were 0.07 and 0.11 nmol/min/mg protein, which was in the lower 5th percentile of the population (Fig. 3a) and immunoreactive b5 and b5R proteins for the two livers were low or virtually undetectable (Fig. 3b) . Interestingly, two bands at 22 and 54 kD that were also recognized by a-b5 antibody in all blots were absent or markedly decreased in the S5A patients (Fig. 4a) . Despite low activities and expression in both livers carrying this SNP, the novel CYB5A S5A SNP was not predicted to be functionally significant by any of the computational methods used (Table 4) , nor was it predicted to be a significant phosphorylation site (NetPhos score=0.157).
Two novel CYB5R3 SNPs (R59H and R297H) were found in one CA patient each. R59H was predicted to be deleterious by SIFT and pathologically significant by PMut, whereas the R297H was predicted to be probably damaging by PolyPhen (Table 4) ; however, screening reduction activities for both cSNPs were comparable with the population mean (Fig. 3a) . The relative expression of immunoreactive b5R protein for the R59H liver was modestly but significantly low (Fig. 3c) ; interestingly, b5R protein from the R297H liver was resolved into two distinct bands (Fig. 4b) . For SIFT, the tolerance index cut-off value was 0.05. For PolyPhen, a positionspecific independent count greater than 1.5 was considered to be damaging. For PMut, a Neural Network Score output greater than 0.5 indicated a pathological mutation, whereas the value in parentheses refers to the prediction reliability index [0 (unreliable) to 9 (highly reliable)].
The CYB5R3 T117S genotype, which was earlier reported in an AA population [27] , was found with a much higher frequency among AA (40%) than CAs (1.1%) in our group of livers (P < 0.0001). Two of the five AA individuals with the b5R T117S genotype also had the b5 S5A SNP. Although the T117S SNP was predicted to be a potential phosphorylation site and a target for phosphokinase C (NetPhos and NetphosK scores=0.58 and 0.78), activities and protein expression for the livers heterozygous for T117S, but without the S5A SNP, were not significantly different from the population mean and median, respectively (Fig. 3) .
The possible effect of coding SNPs on SMX-HA reduction was further assessed by investigating the kinetics for this reaction in all livers with nonsynonymous cSNPs, as well as in a subset of WT livers with outlying high (> 90th percentile for the population; n = 7) or low activities (< 10th percentile, n = 5), as well as a control subset of WT livers with intermediate activities (45-55th percentile, n = 6). The reduction activities in this subset of 18 WT livers were normally distributed, as in the full population, and there were no differences in activities, b5 expression or b5R expression, between this subset and the full study population (P = 0. One S5A liver had an apparent K m for SMX-HA reduction of 395 mmol/l and an apparent V max (0.17 nmol/min/mg), resulting in an enzymatic efficiency (V max /K m ) that fell in the lower 5th percentile of the calculated efficiencies for the WT subpopulation (Fig. 5) . Activities for the second S5A heterozygote, as well as for the liver with undetectable activity on initial screening (which was WT for coding SNPs), were too low to calculate kinetic data.
The two novel CYB5R3 cSNPs (R59H and R297H) exhibited biphasic kinetics (Fig. 6a and c) . The apparent K m1 and V max1 for the R59H liver were 373 mmol/l and 2.06 nmol/min/mg, whereas the estimated parameters for the R297H liver were 355 mmol/l and 1.20 nmol/min/mg. These values were comparable with WT livers. The kinetic parameters for the low-affinity components (K m2 , V max2 ) observed in these heterozygous livers were 1627 mmol/l and 2.94 nmol/min/mg (R59H), and 955 mmol/l and 1.77 nmol/min/mg (R297H). These second apparent K m values were four to six times higher than the mean apparent K m of the subpopulation of 18 WT livers. This resulted in approximately four-fold and two-fold reductions in enzyme efficiency for the lowaffinity components for R59H and R297H, respectively, compared with high-affinity (presumably WT) components (Fig. 5 ).
For four livers with only the CYB5R3 T117S SNP, the mean apparent K m (295 ± 97 mmol/l) and apparent V max (0.97 ± 0.64 nmol/min/mg) values were not significantly different from WT livers (P = 0.77, 0.57 respectively). Michaelis-Menten kinetics were observed for livers with this nonsynonymous CYB5R3 SNP (Fig. 6b) .
Designation of haplotypes was based on the nucleotide sequence of the specific allozyme, with the WT sequence designated as *1A [28] . Haplotype names were designated with letters after the number, with decreasing allele frequency corresponding to increasing alphabetical order. For the coding region of CYB5A there were five haplotypes each for the AA and CA groups; however, only a small number of AAs were evaluated (Table 5) . For CYB5R3, the coding region included six distinct haplotypes, one of which was observed only in AA. Synonymous CYB5A SNPs c.36C > T and c.288G > A were in linkage disequilibrium in the CA and AA groups (D 0 =0.8, r 2 =0.70; D 0 =1.0, r 2 =0.56, respectively). None of the other CYB5A or CYB5R3 SNPs seemed to be linked. No significant differences were found among the various CYB5A *1 allele haplotypes with respect to activity and b5 protein expression.
Discussion
The microsomal b5/b5R reduction pathway is important for the detoxification of the hydroxylamine metabolites of arylamine drugs such as SMX and dapsone [9] , as well as the procarcinogenic hydroxylamine metabolites of 4-aminobiphenyl and 2-amino-1-methyl-6-phenylimidazo Enzyme efficiency (V max /K m ) for sulfamethoxazole hydroxylamine reduction from kinetic determinations in a subset of 18 wild-type human livers, compared with data obtained from livers with CYB5A or CYB5R3 cSNPs. Reduction activities for human livers in the subset were in three defined ranges ( > 90th percentile, n = 7; 45-55th percentile, n = 6; < 10th percentile, n = 5). *R59H and *R297H denote separate calculated efficiencies for the high-affinity components observed in these heterozygous livers. Individual apparent K m and V max values are given in the text. 
The 'wild-type' for each position is indicated in bold type with shaded background. White letters on a dark background indicate the presence of a nonsynonymous SNP, single nucleotide polymorphism. Bold letters on a white background indicate the presence of a synonymous SNP. A blank cell indicates that the haplotype was not observed for that racial group. For allele numbering criteria, please refer to the text. [4,5-b]pyridine [10] . Genetic sequence variation in either CYB5A or CYB5R3 could therefore influence the risk of toxicity from these bioactivated compounds. Although at least 39 exonic and eight intronic mutations in CYB5R3, together with an intronic mutation in CYB5A [29] , have been associated with disease (hereditary methemoglobinemia) to date (reviewed in Ref. [30] ), little is known about the functional significance of less catastrophic or heterozygous SNPs in these genes, which may be more frequent in the population and devoid of any overt clinical symptoms. This study adopted a genotype-phenotype approach to test the hypothesis that coding sequence variability in CYB5A and CYB5R3 contributes to variability in b5 and b5R protein expression and SMX-HA reduction activity in the human liver. In the 111 human livers studied, SMX-HA reduction in human liver microsomes varied about 19-fold, with at least one liver having undetectable activity.
Enzyme activities correlated significantly with the expression of b5 and b5R protein, suggesting that variability in the expression of either enzyme could affect hydroxylamine reduction capacity. In an earlier study on the role of b5 and b5R in hydroxylamine reduction by our laboratory, b5R immunoreactive protein did not correlate with hepatic arylhydroxylamine reduction, a negative finding that may have been because of the narrow range of b5R content in the small number of human livers (n = 11) studied [10] . This study involved a greater number of patients with a wider range in b5R expression.
Lower SMX-HA reduction activities were observed for liver samples from AAs; in fact, 27% of the liver activities from this group were in the lower 5% of the activity distribution, compared with 1% of CA. Erythrocyte ferrihemoglobin reductase activity (a measure of b5 and b5R activity) was previously shown to be increased in a group of clinically ill AA patients in a veterans hospital, relative to CA patients [31] , a finding that is discordant with our results. This suggests that the effects of illness on b5 or b5R expression and function require further investigation.
Although the number of AAs in this population was quite small (n = 15), the decreased SMX-HA reduction observed in this group, in addition to a trend towards decreased b5 protein expression in AA females, warrants further investigation. Although racial differences in SMX hypersensitivity have not been documented, the b5/b5R pathway also detoxifies procarcinogenic N-hydroxylamine metabolites of aromatic and heterocyclic amine carcinogens [10] . It is possible that inefficient b5/b5R-mediated xenobiotic reduction may be a contributory factor to the higher rates of several cancer types seen in AA patients [32, 33] ; this hypothesis is currently under investigation in our laboratory.
The coding region of the microsomal b5 isoform is made up of five exons (exons 1-4, and 6), comprising a total of 402 bases. Including the results from this study, there are now nine known coding SNPs in CYB5A, four of which are nonsynonymous: S5A in exon 1 (this study), R52K (rs1803366) and T60A [16] in exon 2, and the formation of a premature stop codon instead of Y130 in exon 6 (rs19711860). Although the S5A SNP was not predicted in silico to impact reduction activity, both individuals who were heterozygous for this polymorphism displayed markedly low SMX-HA reduction activities. On account of very low activities, it was difficult to obtain accurate kinetic data in more than one S5A liver, although the results in hand indicate a likely decrease in enzymatic efficiency associated with this SNP. As biphasic kinetics were not observed in the heterozygous state, one can hypothesize that the S5A allozyme is essentially inactive or is rapidly degraded; the latter is supported by the low b5 protein expression observed.
The serine 5 residue is at the N-terminus of the b5 protein, and sequence alignment by ClustalW shows that it is conserved across mammals and birds. The crystal structure of human oxidized microsomal cytochrome b5 (PDB ID: 2i96) indicates that the Ser is located in the center of a 'W'-shaped loop with its hydroxyl group within 2.5 Å of the amine group of Lys10, which is the final residue forming this loop. The substitution of Ser by Ala would prevent hydrogen-bond formation and potentially disrupt tertiary structure. This possibility, however, was not considered significant by the PMut and PolyPhen prediction algorithms.
Interestingly, the levels of b5R expression were also significantly low or undetectable for both individuals with the S5A SNP in the b5 gene. In view of the strong correlation between b5 and b5R protein expressions observed in this study, the low activity observed for both S5A heterozygotes could be because, in all or in part, of a deficiency in transcription factor(s) necessary for both genes, rather than the altered amino acid sequence S5A. The functional significance of S5A for b5 function is currently under investigation using site-directed mutagenesis.
An intriguing finding was that two additional proteins that were consistently recognized by a-b5 antibody, at 22 and 54 kD, were absent or markedly decreased in the S5A patients (Fig. 4) . We suspect that these bands represent endoplasmic reticular proteins with cytochrome b5 domains, such as mPR (membrane-associated progesterone component, 22 kD) and possibly NCB5OR (the b5/b5R fusion protein; 59.7 kD); mass spectrometry is underway to confirm this. However, it is as yet unclear why these two other proteins would also be undetectable in S5A patients, unless these proteins are subject to similar transcriptional regulation, as for b5 and b5R, in these individuals.
The coding sequence of CYB5R3 is comprised of nine exons and spans a total of 903 bases. Excluding those variants associated with hereditary methemoglobinemia, there are now 14 coding CYB5R3 SNPs known, which include 10 nonsynonymous sequence variants: R59H (this study) and S66P (rs1130706) in exon 3; T117S (rs1800457) and Q135R (rs11541434) in exon 5; R160G (rs61732609), D162Y (ENSSNP11933047), R170S (rs61743717) in exon 6; E213Q or E213X (rs61745147) in exon 8; and R297H (this study) and V300L or V300F (rs61743746) in exon 9.
The nonsynonymous c.350G > C polymorphism in CYB5R3 (T117S) was found exclusively in the heterozygous state, at an allele frequency of 0.20 in AA in our study. This is similar to the allele frequency of 0.23 that had been previously found in 112 AAs [34] . This study also documented the occurrence of CYB5R3 T117S in CAs, albeit at a very low incidence (one individual). This may account for the low allele frequency (0.08) for T117S reported by the National Institute of Environmental Health Sciences SNPs program, which is derived from the genotyping of 90 individuals of unrecorded ethnicity but 'representative of the US population' (available at http://egp.gs.washington.edu/data/ dia1/). The T117S sequence variation was not associated with significant changes in reduction kinetics or b5R protein expression. For the synonymous CYB5R3 c.132G > A SNP, the reported allele frequency from dbSNP and the National Institute of Environmental Health Sciences SNPs program is 0.075, which is in agreement with the values obtained in this study for both AA and CA patients (0.067, 0.097; Table 3 ).
The WT amino acids at the sites of the nonsynonymous CYB5R3 cSNPs found in this study are well conserved across species, suggesting that these may be functionally important regions. R59H lies at the start of the second b-sheet in the FAD-binding domain of the reductase, and this SNP was predicted to have a pathological and deleterious effect by PMut and SIFT. A homozygous mutation in the preceding arginine residue (R58Q, FTID: VAR004619) is associated with type I congenital methemoglobinemia [35, 36] , possibly because of instability and increased proteolytic susceptibility of the mutant protein. Recombinant enzymatic activity for this adjacent R58Q SNP was 62% of WT [37] ; in our study, the low-affinity microsomal component for heterozygous R59H showed a 67% reduction in efficiency relative to the higher-affinity (presumably WT) component. However, the overall reduction activity for R59H was not significantly lower than the mean population activity, indicating that a biologically significant deleterious effect might only be observed with the SNP in a homozygous state.
The R297H SNP is found in the NADH-binding domain of b5R, close to the C-terminus. This region seems to be important for proper enzyme function as adjacent heterozygous G292D and homozygous F299del mutations result in hereditary methemoglobinemia [38, 39] , and both recombinant G292D and F299del mutant b5R proteins exhibit decreased temperature stability [39, 40] . In addition, the G292D mutation (FTID: VAR037316) in this region is associated with decreased NADH catalytic efficiency, because of misorientation of NADH as a result of disruption of hydrogen bonding between the C-terminus of b5R and the carboxamide group of NADH [40] . A similar defect may have been responsible for the high second K m for SMX-HA observed in the heterozygous R297H liver.
Our kinetic findings of distinct kinetic components for both R59H and R297H heterozygote livers are interesting in light of the immunoblot results for the R297H variant, which showed two b5R protein bands. This was unexpected, because any changes in the enzyme's physical properties on account of the single amino acid change would not typically result in visible electrophoretic separation. It is possible that a posttranslational modification may have taken place that altered the migration of the mutant b5R allozyme. Additional studies are underway to generate purified expressed forms of both R59H and R297H variants, which may help to elucidate the biochemical reason for differential migration of these two apparent R297H allozymes, as well as confirm whether the low enzymatic efficiencies observed for these livers were because of the mutant b5R allozymes.
A number of livers with low activity and/or low b5 or b5R protein expression did not have any SNPs in the coding region (outlying points in Fig. 3a-c) . The possibility of intronic SNPs leading to exon skipping, truncated protein, and low activity could be excluded, as all amplicons of both b5 and b5R cDNAs were of the expected size. It is possible that these samples have sequence variations (rSNPs) in the promoter and/or 3 0 untranslated region of the genes that affect transcriptional regulation. Experimental evidence exists for Sp-binding sites in the CYB5R3 exon 1 mol/l [41] and CYB5A promoters, as well as for NF-1 and GATA-6-binding sites for CYB5A [42] . The high correlation of expression of b5 with b5R protein found in this study suggests shared transcriptional regulation. To this end, work is underway to characterize any common transcriptional regulatory regions for both CYB5A and CYB5R3.
In conclusion, this study showed that SMX-HA reduction in human liver shows nearly 20-fold variation in activity, with lower reduction activities in AAs compared with Caucasians. Expression of hepatic b5 and b5R protein was also variable and in addition was positively correlated with SMX-HA reduction activities, and interestingly, expression of b5 and b5R were highly correlated with one another. A novel nonsynonymous SNP found in CYB5A, S5A, was found in two AA individuals and exhibited low reduction activity, and low expression of both b5 and b5R. The low substrate affinities and overall reduction efficiency observed in livers heterozygous for the CYB5R3 R59H and R297H SNPs may be because of the mutant b5R allozymes. Future work will focus on functional characterization of purified expressed forms of these newly discovered b5 and b5R sequence variants, along with analysis of allele frequencies in a larger number of AAs. Finally, as the novel cSNPs found in this study population were present at low allele frequencies, these cSNPs seem to contribute only a small amount to overall observed phenotypic variability. Work is underway to characterize additional polymorphisms in the promoter and 3 0 untranslated regions of both genes to further account for individual variability in hydroxylamine reduction.
